SUMMARY The efficiency of screening for Wilson' s disease by serum caeruloplasmin determination was assessed by analysing the epidemiologic data of 289 affected families in Japan. The estimated gene frequency was 55 x 103. The sensitivity of the screening test was 93% at a proposed cut-off level of 120 mg/l and the specificity was 99-83%. In Japan 1 500 000 children are bom every year of whom 50 would be expected to have Wilson's disease. The present analysis of potential screening for all children would grade three of them as false-negatives and identify 2621 as false-positives. An analysis for children only from consanguineous marriages produced a more efficient result, with a much higher predictive value of the positive and case-finding rate. Although the number of patients identified in this latter high-risk screening group was small, it is worth considering as a pilot study.
It is now 70 years since Kinnier Wilson drew attention to the relationship between familial nervous disease and cirrhosis of the liver in the same patients." The condition was later found to be an autosomal recessive disorder.23 Prevention of this genetic disease by administration of penicillamine to asymptomatic patients was claimed to be successful,43 and a method of screening by serum caeruloplasmin determination has been considered. A simple and inexpensive way of measuring serum caeruloplasmin using a dried blood spot was recently described.6 However, the efficiency of population screening has not previously been fully discussed. 5 It is the purpose of this paper, therefore, to assess the efficiency of alternative strategies in screening for Wilson's Table 2 shows the sensitivity of the screening test by CP determination at various cut-off levels, derived from the Figure, and the proportion of heterozygotes whose CP value fell below those levels-namely, the proportion of false-positives among heterozygotes, derived from the assumed normal distribution of CP in the parents. The proportion of patients whose serum caeruloplasmin level was below these levels in the study I"The proportion of parents whose serum caeruloplasmin level was below these levels. A normal distnbution with a mean of 204 mg/l and a standard deviation of 84 mg/l, derived from the CP distribution of the parents in the Figure, was used as a CP distribution of heterozygotes. This formula is an algebraic rearrangement of the formula in Table 1 solving for k.
inbreeding unity. It is very likely that in some parts of the country the gene frequency is low and in others it is high, namely, that there exist genetic isolates. In such circumstances the application of the genetic formulae to a whole population leads to a discrepancy between the theoretical and the observed frequency."6 The extent of the discrepancy in this analysis is, however, difficult to estimate and the answer would be obtained from the results of screening. ASSUMPTION 
2
It has been shown that asymptomatic patients show very low CP levels even under the age of 4 and some asymptomatic patients were actually found because of their low CP values.5 Moreover, no statistically significant correlation was observed between CP and age among patients. Even if the correlation was statistically significant, possibly with a larger sample size, the slope of the regression line would be around -1-0 and this would change the age-adjusted distribution of CP very little. It is not unreasonable, therefore, to assume that the majority of asymptomatic patients would show levels below 100 mg/l. The more relevant question, however, is whether the proportion of asymptomatic patients aged about 2 whose CP values are above the cut-off level is similar to that derived from the Figure. The use of the CP distribution in parents as data for heterozygotes aged about 2 requires special attention.
The existence of the correlation between age and CP value among healthy siblings is largely dependent upon the higher values found in the younger siblings. If these higher values were to consist principally of homozygotes, the correlation with age would disappear. The data on 'normal' subjects indicated' 12 It is not impossible that a certain fraction of normal homozygotes have a CP value below 150 mg/l, but the fraction must be very small. If the value of 120 mg/l is taken as a cut-off level, the proportion of normal homozygotes below this level must be smaller still. The answer could be found only from a large-scale survey, which has not been done on these children.
The fact that a low CP was observed in patients with other disease1'25 may also challenge this assumption. In the present analysis this possibility was not considered. In the screening process, however, only apparently 'healthy' children aged about 2 are screened, and the majority of children with these diseases would be easily recognised beforehand. Therefore it is not likely that these diseases would increase the proportion of false-positives among normal homozygotes so greatly as to jeopardise the present analysis.
Menkes's kinky hair syndrome is another disorder with very low CP. The frequency of the disease was estimated to be 1 in 35 000 in Australia.2" The patients were identifiable by CP determination.6 It is therefore of interest to consider screening for this disease in combination with screening for Wilson's disease. One of the problems, however, is the age at screening. Most patients with Menkes's syndrome develop the disease in infancy, and pathological changes occur quite early in infancy,26 so screening needs to be done at that time, which poses a dilemma. A large overlap of CP value between affected and normal children is expected in screening for Wilson' s disease and possibly for Menkes's disease. It would be premature to discuss the possibility of combined screening without gaining further evidence.
Also, the accuracy and precision of whichever screening test is used need to be assessed.
Apart from the assumptions discussed above, some other questions need to be considered.
The most important question in screening is how to identify the asymptomatic patients among the referrals. There are several ways of distinguishing between genotypes but unfortunately none of them seems to be completely efficient. The clinical test using radio copper seems to be quite effective20 27 Screening children from consanguineous marriages seems to give worthwhile results. The predictive value of the positive and the case-finding rate are much higher than in the general population. However, one drawback is that only a proportion of the patients we have every year are identified; the proportion depends upon the rate of consanguinity in the 1980s. Nevertheless, it may be worthwhile to do it as a pilot study. It offers useful information, such as the efficiency of screening and the gene frequencies in different geographical areas, which will be useful for future screening in high-risk areas.
The information on consanguinity will be obtained from the Maternal and child health record book handed to every pregnant woman in Japan, or by asking parents at the time of immunisation or regular health screening of infants.
Recent reports on neonatal screening for congenital metabolic disorders in Japan revealed the following incidence of each disease30; phenylketonuria 1/59900; maple syrup urine disease 1/671300; histidinemia 1/8100; homocystinuria 1/145900; galactosemia 1/139800; and congenital hypothyroidism 1/8200. Wilson's disease seems to be comparable to these disorders judging from the principles of screening -laid out by Wilson and Junger.'1 Cost and benefit of the screening need to be assessed further.
In summary, the conclusions of this analysis are as follows. It would be worth screening children from consanguineous marriages for Wilson's disease at the age of about 2 as a pilot study. A cut-off level for screening placed at around 120 mg/l would be most useful.
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